Nexium (Esomeprazole) & Bone Health in Postmenopausal Women: Osteoarthritis vs. Osteoporosis Risk
Osteoarthritis
No evidence links PPIs like Nexium to osteoarthritis. OA is a degenerative joint disease from mechanical wear, not medication-induced.
Osteoporosis
Some observational studies suggest long-term PPI use may modestly increase fracture risk in postmenopausal women, possibly by reducing calcium absorption. However, data are mixed; randomized trials have not consistently confirmed this.
Clinical Recommendations
- Use lowest effective PPI dose for shortest duration.
- Ensure adequate calcium (1200 mg/day) and vitamin D (800–1000 IU/day) intake.
- Weight-bearing exercise.
- Discuss bone density screening (DEXA) with your doctor if on chronic PPI therapy.
Do not stop prescribed PPIs without medical advice; weigh benefits against potential risks.
Osteoporosis - Related Articles
- Osteoporosis Treatment: Latest Medications & Therapies for Postmenopausal Women
- Effective Alternative Therapies for Osteoporosis
- Exercise for Osteoporosis: Strengthen Bones & Reduce Fracture Risk
- Osteopenia: The Precursor to Osteoporosis
- Fat & Bone Health: Does a Low-Fat Diet Increase Osteoporosis Risk?
- Osteoporosis Treatments: Diet, Exercise, and Supplements
- Osteoporosis Medications: A Comprehensive Guide to Treatment Options
